ADGM
Adagio Medical Holdings, Inc.Company with tickers: ADGM
CIK
2006986
CUSIP
00534B100
Shares Outstanding
22,210,459
Website
https://us.adagiomedical.com
13F Activity (30d)
4 filings
4 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $2,741,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-5,200,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-6,995,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.31 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.31 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2023-12-31 |
|---|---|
| Single Reportable Segment | $300,000 |